This trial is active, not recruiting.

Condition cancer
Treatment survey
Sponsor Abramson Cancer Center of the University of Pennsylvania
Start date September 2014
End date February 2016
Trial size 466 participants
Trial identifier NCT02559375, UPCC 26914


This study will increase knowledge of patient preferences for pain treatments, and improve the ability to meet patients pain management needs. This study will assess patient attitudes towards underutilized treatments and identify technologies to increase awareness of such treatments. This study also demonstrate the feasibility of using the Penn Cancer Network in future clinical and cancer control research and better understand how to effectively raise patients awareness of supportive cancer services.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Number of subjects providing completed surveys
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Age 18 or older; Have a primary diagnosis of cancer; - Have a Karnofsky functional score of 60 or greater (i.e. ambulatory); - Understand written English; - Verbally indicate to the RA/RN that they feel physically well enough to complete a survey at the time of approach; - Report experiencing nonzero pain (on a scale of 0-10) in the last seven days Exclusion Criteria: - An inability to understand the requirements of the survey

Additional Information

Official title PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
Principal investigator Jun Mao, MD
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Abramson Cancer Center of the University of Pennsylvania.